News Shire CEO backs outcomes-based deals in rare diseases Strategy could help make rare disease drugs affordable
News GSK hires Calico's Hal Barron to lead R&D with bumper pay pa... GSK has pulled off a major coup, replacing outgoing chief science officer Patrick Vallance with Calico and former Roche/Genentech whizz, Dr Hal Barron with a bumper pay package that could b
News US tech firm takes aim at immuno-oncology outcomes Company expands cancer patient monitoring platform to include checkpoint inhibitors.
News Cellectis gets FDA go-ahead to restart fatal CAR-T trial Regulator agrees to restart phase 1 trial of UCART 123
News Moderna's Q1 revenues rocket, thanks to ex-US sales Moderna saw its Q1 sales nearly triple to $389m, almost a threefold rise on the same period of 2025, with international markets driving the increase.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
